Sort
85,873 grants matching “alzheimers”
Changes in Functioning among Mentally Retarded Adults
$1,020,253Hugo W. Moser Res Inst Kennedy Krieger · P01 · FY2005 · HD
Enhancing access to multi-omic data assets in the AMP-AD research ecosystem
$1,020,000Lara M Mangravite · Sage Bionetworks · U24 · FY2020 · AG
Axonal mitochondrial mobility and its impact on synaptic transmission
$1,019,916Zu-Hang Sheng · Neurological Disorders And Stroke · Z01 · FY2007 · NS
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease
$1,019,854Jeremy H. Herskowitz · University Of Alabama At Birmingham · R01 · FY2020 · AG
Core B: Health Events and Endpoints
$1,019,655Mark Raymond Nelson · Hennepin Healthcare Research Institute · U19 · FY2020 · AG
Extracranial Carotid Atherosclerosis Contributions to Cognitive Impairment and Alzheimer's Disease Risk
$1,019,526Craig C Weinkauf · University Of Arizona · R01 · FY2022 · AG
ACETYLCHOLINE MODULATION OF NEURONAL EXCITABILITY
$1,019,523Harvard University (Medical School) · P01 · FY2003 · NS
Role of inflammasomes in Alzheimer's Disease
$1,019,436Douglas T. Golenbock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · AG
PREVENTABLE Administrative and Trial Management
$1,019,217Karen P Alexander · Duke University · U19 · FY2020 · AG
ALZHEIMERS DISEASE CENTER CORE
$1,019,108University Of Pennsylvania · P30 · FY2000 · AG
Neuroprotective role of GLP-1 receptor agonists
$1,019,063Nigel H. Greig · National Institute On Aging · ZIA · FY2020 · AG
New Mexico Alzheimer's Disease Research Center
$1,019,037Gary Allen Rosenberg · University Of New Mexico Health Scis Ctr · P20 · FY2022 · AG
The impact of adverse interpersonal experiences (AIE) on mild cognitive impairment (MCI) and risk for Alzheimer's disease and related dementias (ADRD) in ethnically diverse twins
$1,018,998Robert F Krueger · University Of Minnesota · R01 · FY2024 · AG
BDNF Regulation: Roles in Plasticity and Neuroprotection
$1,018,969University Of California Irvine · P01 · FY2004 · NS
Mechanistic links between the benefits of pharmacologically high thiamine (vitamin B1) in Alzheimer's disease to Advanced Glycation Endproducts (AGE)
$1,018,953Gary E Gibson · Winifred Masterson Burke Med Res Inst · R01 · FY2024 · AG
Targeted Therapies for Myasthenia Gravis
$1,018,947Henry J Kaminski · Saint Louis University · R24 · FY2007 · EY
Long Life Family Study: Columbia University
$1,018,707Richard Mayeux · Columbia University Health Sciences · U01 · FY2015 · AG
National Biomedical Resource for Electron-Spin Resonance Spectroscopy (ACERT)
$1,018,507Jack H Freed · Cornell University · R24 · FY2024 · GM
National Biomedical Resource for Electron-Spin Resonance Spectroscopy (ACERT)
$1,018,507Jack H Freed · Cornell University · R24 · FY2025 · GM
Neocortical microarchitecture of executive function using large-scale intracranial electrophysiology
$1,018,155Daniel R Kramer · University Of Colorado Denver · R61 · FY2024 · DC
Brain Banking Core
$1,018,103Edward Byung-Ha Lee · University Of Pennsylvania · U54 · FY2023 · NS
NEUROIMAGING ANALYSIS CENTER
$1,018,064Brigham And Women'S Hospital · P41 · FY2000 · RR
Safety and Tolerability Studies for an Anti-Fibrin P2 Monoclonal Antibody for the Treatment of Alzheimer's Disease
$1,017,452Jeffrey Stavenhagen · Therini Bio, Inc. · U01 · FY2022 · AG
Alzheimers Disease Mechanism &Experimental Therapeutic
$1,017,418Johns Hopkins University · P01 · FY2005 · NS
Genetic Influences on Infant Brain Development: Understanding the Developmental Origins of Mental Illness
$1,017,201Rebecca Knickmeyer · Michigan State University · R01 · FY2024 · MH